Southmedic Inc.
$337,900.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2019-2020
Canada
Southmedic is developing a second generation of its Oxymask O2 and ETCO2 products, which are based on the same underlying technology. The second generation significantly improves the clinical effectiv...